Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT AND CEO

CHIEF FINANCIAL OFFICER

CHIEF SCIENTIFIC OFFICER

President and CEO

Chief Financial Officer

Chief Business Officer

Chief Scientific Officer

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT AND CEO
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF SCIENTIFIC OFFICER
2023-09-11	Premium	bought	Premium	Premium	Premium	President and CEO
2023-07-31	Premium	back to issuer	Premium	Premium	Premium	-
2023-07-31	Premium	back to issuer	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-07-10	Premium	acquired	Premium	Premium	Premium	-
2023-06-01	Premium	sold	Premium	Premium	Premium	-
2023-06-01	Premium	sold	Premium	Premium	Premium	-
2023-02-23	Premium	bought	Premium	Premium	Premium	-
2023-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-02-15	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2023-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Business Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Business Officer

SNSE - Sensei Biotherapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for SNSE